MedTrace Logo

DART: Diagnostic-CT-Enabled Planning: A Randomized Trial in Palliative Radiation Therapy

NCT05233904 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2022-06-13

No results posted yet for this study

Summary

The objective of this trial is to assess the efficacy, acceptability, and scalability of diagnostic-CT-enabled planning, compared to conventional CT simulation planning.

Conditions

  • Advanced Cancer Requiring Palliative Radiation

Interventions

DIAGNOSTIC_TEST

Diagnostic-CT-enabled Planning

Diagnostic-CT-enabled planning for patient receiving palliative radiation treatment to bone, soft tissue and lung disease

DIAGNOSTIC_TEST

Standard of Care

Patients will be booked for CT simulation and treatment as per the local institution's standard practice

Sponsors & Collaborators

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • David Palma, MD · London Health Sciences Centre, Lawson Health Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-08
Primary Completion
2023-06-01
Completion
2023-08-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05233904 on ClinicalTrials.gov